Skip to main content

Table 3 XP-D Patient Findings

From: Differences in peripheral neuropathy in xeroderma pigmentosum complementation groups A and D as evaluated by nerve conduction studies

Patient

Age at Test Date

Sex

Neuropathy

Audiology

MRI/CT Imaging

IQ Testing

DTR

ID # (Protocol designated ID)

  

Abn SNC

Abn MNC

SNHL

Cerebral Atrophy

Cerebellar Atrophy

Hypo- myelination

IQ < 80

Absent

XPD1 (XP29BE)a-c

22

M

+

–

Mod

3

2

–

+

+

XPD2 (XP528BE)

19

M

+

–

Mild

1

0

–

+

+

XPD3 (XP32BE)

42

M

+

–

Mild

2

1

ND

ND

+

XPD4 (XP33BE)a

31

F

+

–

Mod

2

1

–

+

+

XPD5 (XP400BE)

17

M

+

–

Mild

1

0

–

+

+

XPD6 (XP116BE)

5

F

–

–

Normal

0

0

–

–

+

XPD7 (XP82BE)

11

F

–

–

Normal

0

0

–

–

ND

XPD8 (XP30BR-D)

13

M

–

–

Normal

0

0

–

–

ND

XPD9 (XP341BE)

3

M

–

–

Normal

0

0

–

+

_

XPD10 (XP416BE)

13

F

–

–

Normal

0

0

–

+

–

  1. Abbreviations: XPD Xeroderma pigmentosum – D, F Female, M Male, Abn Abnormal, SNC Sensory nerve conduction studies, MNC Motor nerve conduction studies (fibular nerve), MRI Magnetic resonance imaging, CT Computed tomography, IQ Intelligence quotient, DTR Deep tendon reflexes, ND Not done, Mod Moderate
  2. Footnotes: a Totonchy MB, et al. 2013 (Ref. [5]), b Ueda T, et al. 2009 (Ref. [14]), c Zhou X, et al. 2013 (Ref. [15])